These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 5716215)
41. [Galactorrhea and neuroleptics]. Plante N; Roy P Laval Med; 1967 Jan; 38(1):103-7. PubMed ID: 5628184 [No Abstract] [Full Text] [Related]
42. [Paroxysmal extrapyramidal syndrome caused by taking neuroleptic drugs]. Gurovich IIa; Fleĭs EP Klin Med (Mosk); 1969 Sep; 47(9):132-7. PubMed ID: 5397873 [No Abstract] [Full Text] [Related]
43. [Adverse effects of neurolepitcs from the biochemical viewpoint]. Kluge H; Hartmann W; Wieczorek V Z Arztl Fortbild (Jena); 1974 Nov; 68(22):1207-9. PubMed ID: 4156445 [No Abstract] [Full Text] [Related]
44. [On the differential diagnosis of hyperkinetic, dystonic side effects of psychopharmaca]. Bellabarba U; Hippius H; Kanowski S Med Welt; 1967 Mar; 10():559-63. PubMed ID: 5587137 [No Abstract] [Full Text] [Related]
45. [Trial of a new neuroleptic, perimethazine, in major digestive surgery]. Rocchiccioli B; Alluaume R Presse Med (1893); 1968 Oct; 76(41):1967-8. PubMed ID: 5724623 [No Abstract] [Full Text] [Related]
46. A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital. Guttman H; Lehmann HE; Ban TA Laval Med; 1970 Apr; 41(4):449-55. PubMed ID: 5515661 [No Abstract] [Full Text] [Related]
47. Prochlorperazine-induced extrapyramidal effects mimicking meningitis in a child. Muñiz AE South Med J; 2000 Jun; 93(6):629-30. PubMed ID: 10881788 [TBL] [Abstract][Full Text] [Related]
49. Major tranquilizers: the phenothiazines. Farrow J Tex Med; 1972 Jul; 68(7):51-3. PubMed ID: 5064650 [No Abstract] [Full Text] [Related]
50. "Miscellaneous" side effects during prolonged phenothiazine therapy. Zabors TE Wis Med J; 1967 Feb; 66(2):115-7. PubMed ID: 5342511 [No Abstract] [Full Text] [Related]
51. Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients. Ananth JV; Horodesky S; Lehmann HE; Ban TA Laval Med; 1970 Sep; 41(7):934-8. PubMed ID: 5509491 [No Abstract] [Full Text] [Related]
52. Extra pyramidal manifestations following phenothiazines therapy. Report of 10 cases with review of Indian literature. Mittal MM; Gupta SK; Misra RC J Assoc Physicians India; 1970 Aug; 18(8):691-6. PubMed ID: 5480839 [No Abstract] [Full Text] [Related]
53. [Persistent extrapyramidal syndrome in neuroleptic therapy]. Hoff H; Hofmann G Wien Med Wochenschr; 1967 Jan; 117(1):14-7. PubMed ID: 6031954 [No Abstract] [Full Text] [Related]
54. [Psychiatry and immunology: contribution to experimental study of the immunodepressive effect of a corrector of extrapyramidal syndromes induced by neuroleptics: ethybenzatropine]. Borenstein P; Schneider M; Hayat M; Mascaro G; Cujo P Ann Med Psychol (Paris); 1971 Mar; 1(3):424-30. PubMed ID: 5558677 [No Abstract] [Full Text] [Related]
55. [Symptoms of the extrapyramidal syndrome during maintenence therapy with neuroleptic drugs]. Sujecka-Szymkiewicz H Psychiatr Pol; 1967; 1(1):79-84. PubMed ID: 4876412 [No Abstract] [Full Text] [Related]
56. [Effect of a new phenothiazine derivative--fluophenazine--on extrapyramidal manifestations of a hyperkinetic type]. REBUCCI GG G Psichiatr Neuropatol; 1962; 90():269-82. PubMed ID: 14490858 [No Abstract] [Full Text] [Related]
58. Ocular complications related to phenothiazines. Siddall JR Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740 [No Abstract] [Full Text] [Related]
59. Psychotropic drugs used in the management of schizophrenia. Bueno JR; Himwich HE Int J Neurol; 1967; 6(1):77-93. PubMed ID: 5630202 [No Abstract] [Full Text] [Related]
60. [Diseases treatable by stereotaxic technics. Treatment of motor disorders]. Mundinger F Z Allgemeinmed; 1974 Jun; 50(18):822-6. PubMed ID: 4605628 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]